Department of Orthopedics, Xinqiao Hospital, Third Millitary Medical University, Chongqing, People's Repulic of China.
PLoS One. 2012;7(8):e43984. doi: 10.1371/journal.pone.0043984. Epub 2012 Aug 27.
Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that regulates inflammatory reactions and the pathophysiology of many inflammatory diseases. Intervertebral disc (IVD) degeneration is characterized by an inflammatory reaction, but the potential role of MIF in IVD degeneration has not been determined. Recent studies have shown that MIF and its receptor, CD74, are involved in regulating the migration of human mesenchymal stem cells (MSCs); Thus, MIF might impair the ability of mesenchymal stem cells (MSCs) to home to injured tissues. Our previous studies indicated that cartilage endplate (CEP)-derived stem cells (CESCs) as a type of MSCs exist in human degenerate IVDs. Here, we investigate the role of MIF in regulating the migration of CESCs.
CESCs were isolated and identified. We have shown that MIF was distributed in human degenerate IVD tissues and was subject to regulation by the pro-inflammatory cytokine TNF-α. Furthermore, in vitro cell migration assays revealed that nucleus pulposus (NP) cells inhibited the migration of CESCs in a number-dependent manner, and ELISA assays revealed that the amount of MIF in conditioned medium (CM) was significantly increased as a function of increasing cell number. Additionally, recombinant human MIF (r-MIF) inhibited the migration of CESCs in a dose-dependent manner. CESCs migration was restored when an antagonist of MIF, (S, R)-3(4-hydroxyphenyl)-4, 5-dihydro-5-isoxazole acetic acid methyl ester (ISO-1), was added. Finally, a CD74 activating antibody (CD74Ab) was used to examine the effect of CD74 on CESCs motility and inhibited the migration of CESCs in a dose-dependent manner.
We have identified and characterized a novel regulatory mechanism governing cell migration during IVD degeneration. The results will benefit understanding of another possible mechanism for IVD degeneration, and might provide a new method to repair degenerate IVD by enhancing CESCs migration to degenerated NP tissues to exert their regenerative effects.
巨噬细胞移动抑制因子(MIF)是一种多功能细胞因子,可调节炎症反应和许多炎症性疾病的病理生理学。椎间盘(IVD)退变的特征是炎症反应,但 MIF 在 IVD 退变中的潜在作用尚未确定。最近的研究表明,MIF 及其受体 CD74 参与调节人间充质干细胞(MSCs)的迁移;因此,MIF 可能会损害间充质干细胞(MSCs)向受损组织归巢的能力。我们之前的研究表明,软骨终板(CEP)衍生的干细胞(CESCs)作为一种 MSCs 存在于人类退变的 IVD 中。在这里,我们研究了 MIF 在调节 CESCs 迁移中的作用。
分离和鉴定 CESCs。我们已经表明,MIF 分布在人类退变的 IVD 组织中,并受到促炎细胞因子 TNF-α的调节。此外,体外细胞迁移实验表明,核髓(NP)细胞以数量依赖性方式抑制 CESCs 的迁移,ELISA 实验表明,条件培养基(CM)中 MIF 的量随着细胞数量的增加而显著增加。此外,重组人 MIF(r-MIF)以剂量依赖性方式抑制 CESCs 的迁移。当添加 MIF 的拮抗剂(S,R)-3(4-羟基苯基)-4,5-二氢-5-异恶唑乙酸甲酯(ISO-1)时,CESCs 的迁移得到恢复。最后,使用 CD74 激活抗体(CD74Ab)来检查 CD74 对 CESCs 运动性的影响,并以剂量依赖性方式抑制 CESCs 的迁移。
我们已经确定并描述了一种调节 IVD 退变过程中细胞迁移的新调节机制。这些结果将有助于理解 IVD 退变的另一种可能机制,并可能通过增强 CESCs 向退变的 NP 组织迁移来发挥其再生作用,为修复退变的 IVD 提供一种新方法。